Showing 561-570 of 7446 results for "".
Radiesse for Hands, Alevicyn Cleared
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-radiesse-for-hands-alevicyn-cleared/18898/Merz gets FDA approval for Radiesse for hand augmentation and releases data comparing Xeomin to Botox. Heidi Waldorf, MD, FAAD and Michael Gold, MD, FAAD, comment. Also in this edition, Galderma participate in a White House forum on antibiotic stewardship, and the FDA gives 510(k) clearance to AleviDos and don'ts for creating a killer Google Adwords Campaign for your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/dos-and-don-ts-for-creating-a-killer-google-adwords-campaign-for-your-dermatology-practice/18907/Google AdWords could be a great way to promote your practice. But you have to do it right! Learn how to plan and implement a campaign that gets results with reasonable costs.Kythera's Kybella Approved; ASLMS Update
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-kythera-s-kybella-approved-aslms-update/18925/FDA Approves Kythera's Kybella (ATX-101 or deoxycholic acid) injection for reduction of sub mental fullness or double chin. ASLMS Recognizes women in device-based medicine (Women in Energy-based Devices). Deka and Syneron get new clearances. ASDS Launches Skin Cancer PSAs, and Foamix sells shares.Beware of Your CPA's Advice on Asset Protection
https://practicaldermatology.com/topics/practice-management/beware-of-your-cpas-advice-on-asset-protection/21234/The advice you get may be inaccurate.Cynosure Acquires Ellman International
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-cynosure-acquires-ellman-international/19059/Cynosure Acquires Assets of Ellman International, NPF Ramps Up Patient Advocacy, New App Available for Practice, PLUS: Acne Insights.DermwireTV — Valeant Ups Allergan Bid, Nestle Buys Injectables, and Allergan Makes Its Case
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-valeant-ups-allergan-bid-nestle-buys-injectables-and-allergan-makes-its-case/19128/BREAKING NEWS: Valeant has increased its offer for Allergan to $72 per share. Read more. Valeant sells the rights to its aesthetic injectables to Nestle, while Allergan touts physician support and challenges Valeant's business model. In this week's edition of DermWireTV, learn about Valeant's latesIndoor Tanning Beds: The Dangers of Adolescent Tanning
https://practicaldermatology.com/topics/skin-cancer-photoprotection/indoor-tanning-beds-the-dangers-of-adolescent-tanning/22972/As research continues to shed light on the connection between UV exposure and skin cancer, greater efforts are required to inform the public and affect the legislative process.Critical Factors to Advancing Melanoma Diagnosis and Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/critical-factors-to-advancing-melanoma-diagnosis-and-treatment/22970/Dermatologists need to stay abreast of technologies for evaluation of lesions and ensure that medical oncologists within their referral network recognize the importance of clinical trials.Taking the Pulse of Device-based Aesthetics Procedures
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/taking-the-pulse-of-device-based-aesthetics-procedures/22956/With new developments in store, the evolution of devices for aesthetic procedures is creating new possibilities.ASDS Survey: 8 Million Procedures in 2012
https://practicaldermatology.com/topics/practice-management/asds-survey-8-million-procedures-in-2012/19259/"More and more people are seeking care from dermatologic surgeons." ASDS President Timothy Flynn, MD addresses new findings about the public's dependence on dermatologic surgeons. Derm surgeons' expertise and training in cosmetic and medical care are discussed.